Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South KoreaHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South KoreaCNW GroupJanuary 7, 2020ReblogShareTweetShareSINGAPORE , Jan. 6, 2020 /CNW/ -- Mundipharma has announced today that it has sealed an exclusive sales agreement with Biosolution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-generation autologous chondrocyte implantation product, CartiLife®.View photosMundipharma Announces Exclusive Deal for Biosolution's Cartilife(R) in South KoreaMore View photosBiosolution Co., Ltd and Mundipharma LogoMoreCartiLife® is an autologous cartilage-derived chondrocyte cell therapy for the treatment of cartilage defects (ICRS grade 3 or 4). Its key benefits include significantly reduced risk of host-immune rejection due to its autologous nature, direct restoration of hyaline cartilage, and a less invasive surgery followed by shorter recovery times compared to alternative, comparable therapies.Under the agreement, Mundipharma obtains the rights to market and distribute CartiLife® in South Korea ."We are delighted to extend our relationship with Biosolution to include CartiLife®, which adds to our portfolio of products for orthopedic care," said Mundipharma's CEO, Raman Singh . "It is also another example of our support for innovative treatments developed in Asia and our ability to increase their market presence."This is the second deal between Mundipharma and Biosolution Co., Ltd following the exclusive sales agreement for the allogeneic keratinocyte cell therapy product, KeraHeal-Allo™, which was announced in May 2016 .About Biosolution Co ., Ltd . Biosolution Co., Ltd. manufactures and distributes pharmaceuticals. The Company produces cell therapy products, human tissue models, and other related products. Biosolution markets its products throughout South Korea . Biosolution Co., Ltd sells Keraheal, a cell therapy that has a 70 percent share in the severe burn treatment market.About MundipharmaMundipharma's independent associated companies are privately owned entities covering the world's pharmaceutical markets. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients with cancer and non-cancer pain and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients with severe and debilitating diseases the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.Story continuesFor more information please visit: www.mundipharma.com.sg.CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/mundipharma-announces-exclusive-deal-for-biosolutions-cartilifer-in-south-korea-300982225.htmlSOURCE MundipharmaView photosView original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2020/06/c1390.htmlReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextKorea Cases Top 2,000; Nigeria Confirms Infection: Virus UpdateBloombergGlobal coronavirus cases rise as China’s downward trend continuesPA Media: World NewsBTS cancel concerts as South Korea coronavirus cases pass 2,000AFPHyundai suspends output at one factory after worker tests positive for coronavirus - sourceReutersThe 6 largest coronavirus outbreaks outside of ChinaCBS NewsBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloomberg'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatch